Le Lézard
Classified in: Science and technology
Subject: SVY

Global Artificial Eye Market Outlook to 2023 by Product, Geography and Vendor


DUBLIN, Dec 14, 2018 /PRNewswire/ --

The "Global Artificial Eye Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The artificial eye market to grow at a CAGR of close to 8% by 2023.

The psychological well-being of individuals can be affected by ophthalmic defects or injuries caused due to trauma, ophthalmology diseases, retinal cancer, and individuals with moderately shrunken eyeballs or children with anophthalmos or microphthalmos.

Hence, companies are focusing on developing custom-made prosthetic eyes that improve the confidence and improves the psychological wellness of patients. Therefore, the increasing demand for custom-made ocular prosthetics is boosting the overall growth of the artificial eye market.

Increase the prevalence of ophthalmic diseases

Over the years, the prevalence of ophthalmic diseases has been increasing, which is driving the demand for ocular prosthesis across the world. The incidence of severe injuries, congenital eye diseases, and other severe eye diseases that result in loss of eyes are increasing the demand for artificial eyes, which ultimately drives the global market.

High device and implantation cost

Artificial eyes and implantation procedures are expensive. The high cost of artificial eyes makes it expensive for end-users without insurance coverage. In fact, some medical insurance plans do not cover the entire cost of prosthetic eye implantations. This is expected to be a major challenge for the global artificial eye market.

Competitive Landscape

With the presence of a considerable number of companies, this market appears to be highly fragmented. Most of the artificial eye suppliers are focused on developing custom-made ocular prosthesis due to the growing demand for personalized and customized eye care.

Key Players


Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: MARKET SIZING

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY PRODUCT

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

PART 13: VENDOR ANALYSIS

For more information about this report visit https://www.researchandmarkets.com/research/x2362c/global_artificial?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:


Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

SOURCE Research and Markets


These press releases may also interest you

at 03:07
Global consulting firm J.S. Held, proudly celebrating 50 transformative years, announces the promotion of 93 distinguished experts across multiple practices and geographies. These well-deserved senior expert promotions span the firm's areas of...

at 03:07
Creative Group, a full-service meeting, incentive, and recognition agency, is thrilled to announce the resounding success of its clients' 2023 incentive programs, showcasing a remarkable return on investment and unprecedented participant engagement....

at 03:01
New research from Beko, the home appliance brand, has revealed the most weird and wonderful items that consumers have inherited. 77%...

at 03:00
DWF Labs, a new generation Web3 investor, will be onboarding as Klaytn's latest Governance Council (GC) member, with their GC membership application having passed on-chain voting with 98% in favor. In a bold move to demonstrate their commitment to...

at 03:00
Today McLeod Software announced their enhanced solution for private fleet trucking operations, called LoadMaster Private Fleet. The solution is built on the company's proven LoadMaster Enterprise operations software, already used by dozens of private...

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...



News published on and distributed by: